Oral Sortilin Inhibitor VES001 Safely Raises Progranulin in First Human Trial
A phase 1 randomized trial in 79 healthy adults demonstrates that the oral small-molecule sortilin inhibitor VES001 is well tolerated, ...
A phase 1 randomized trial in 79 healthy adults demonstrates that the oral small-molecule sortilin inhibitor VES001 is well tolerated, ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.